Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy

This study has been terminated.
(Poor compliance with the therapy and lot of patients were lost to follow up.)
Information provided by:
Hebei Medical University Identifier:
First received: July 29, 2005
Last updated: July 13, 2009
Last verified: December 2008
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2009
  Estimated Primary Completion Date: No date given